Skip to content
SCNIScinai Immunotherapeutics Ltd.

Earnings

When Scinai Immunotherapeutics Ltd. reports, what it reported each quarter, and how the stock took the results.

7 quarters. Sep 30, 2019 to Jun 30, 2023. mixed units.

Quarter by quarter

Q2 2023-$3.76MNo Q2 2022 on file

Latest results

  1. Q1 2023May 15, 2023, after the close
    Revenue
    —
    —
    Net income
    -$3.52M
    N/M
    EPS
    -$0.00
    N/M

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2023
Q2 2023Jun 30, 2023——————-$0.00—
Q1 2023Mar 31, 2023—May 15, 202345 d10-Q——-$0.00—
FY 2022
Q2 2022Jun 30, 2022——————-$0.00—
Q1 2022Mar 31, 2022——————-$0.00—
FY 2021
Q4 2021derivedDec 31, 2021————————
Earlier years, FY 2019 to FY 2020

Source filings

10-QMay 15, 2023039875
10-KApr 17, 2023030228

Provenance

ProvenanceData status and checks

Scinai Immunotherapeutics Ltd. · CIK 1611747 · Engraved from SEC EDGAR